You are here

Message from the SIOG 2020 Annual Meeting Co-Chairs

The coronavirus pandemic has dramatically affected health care professionals and patients worldwide. This is a very unsettling time for everyone and everywhere. In light of the current circumstances and in abundance of caution, travel and attendance could not return to normal by the time of the 2020 SIOG Annual Conference.

The SIOG 2020 Annual Meeting Online will ensure that the geriatric oncology community continues to connect and collaborate, in times when live attendance is not possible due this serious global health challenge. The pandemic has impacted the treatment and care of our older patients. Join SIOG 2020 and contribute.

The programme will comprise of:

  • A short celebration of the 20th anniversary of SIOG;
  • Presentations from the SIOG Working Group on COVID-19 including discussion of ethical issues;
  • Rapid fire abstracts;
  • Updates in Geriatric Oncology;
  • General Assembly (SIOG members only).

We look forward to seeing you at this meeting and hope that you will enjoy the benefits of the remote session to the fullest.

Kind greetings,

Dr Holly Holmes and Prof KL Cheung
Co-chairs,
SIOG 2020 Annual Meeting Online

SIOG 2020 Scientific Committee

Co-chairs

Holly Holmes,
USA
Kwok-Leung Cheung,
UK

Members

Nicolo Matteo Luca Battisti,
UK
Raúl Córdoba Mascuñano,
Spain
Nienke de Glas,
The Netherlands
Theodora Karnakis,
Brazil
Melissa Loh,
USA
Isacco Montroni,
Italy
Lucinda Morris,
Australia
Martine Puts,
Canada
Hans Wildiers,
Belgium

The Annual Meeting Online will be held on Thursday, October 1 - 03:00-06:00pm (CET) through Zoom.

For any questions please contact
Ms. Lara Volkan
E-mail: lvolkan@kenes.com

Registration Fees

Registration fees are non-refundable for any cancellations requested after completing your registration payment.

SIOG gratefully acknowledges contribution of the following companies:

At Eisai, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy. We are the European hub of Tokyo-based Eisai Co. Ltd., forming part of a multinational team working across a global network of R&D facilities, manufacturing sites and marketing subsidiaries.  Our collective passion and dedication to patient care is the driving force behind our efforts to discover and develop innovative medicines in a variety of therapeutic areas in which a high unmet medical need remains, including oncology and neurology.  Our mission is clear; we strive to make a significant long-lasting contribution to society in an ethical, compliant and sustainable way by embodying our hhc philosophy in everything we do.

Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on developing therapies in oncology, rare diseases, rare blood disorders, multiple sclerosis, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. In oncology, we are building on a rich legacy with a strong pipeline and a continued commitment to contribute meaningful solutions for patients with cancer. Through rigorous drug discovery and development rooted in cutting-edge science and innovative technologies, we are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com.

 

The International Society of Geriatric Oncology (SIOG) is organising a webinar on the Impact of COVID-19 on older adults with cancer. SIOG is pleased to have the World Health Organisation fully represented. Public health leaders, speakers from Governments, Ministries of Health and Institutions will join the conversation.

This webinar will be held on September 30, 2020 at 2:00-3:00pm CET.

The COVID-19 pandemic poses a barrier to equal and evidence-based management of cancer in older adults.  Age and cancer diagnosis are significant predictors of adverse outcomes of the COVID-19 infection. The International Society of Geriatric Oncology (SIOG) formed a panel of experts to develop consensus recommendations on the implications of the pandemic on several aspects of cancer care in this age group.The webinar will aim to elucidate the challenges of managing cancer in older individuals during the COVID-19 pandemic and outline relevant policies to address this challenge.

This event is FREE. Register to receive the Zoom link. Certificate of attendance will be provided.

SIOG COVID-19 Support Fund

The SIOG Annual Conference is the time of the year, when our members renew their annual commitment to the geriatric oncology network.
SIOG’s activities have been strongly impacted by the pandemic. Make a donation to support our geriatric oncologists’ education projects.

General Inquiries
Ms. Pinar Akbulut
Project Manager
E-mail: pakbulut@kenes.com

Registration, Accommodation & Travel Inquiries
Ms. Lara Volkan
Registration & Accommodation Specialist
E-mail: lvolkan@kenes.com

Scientific Related Inquiries
Ms. Neyir Utugen
Scientific Programme Coordinator
E-mail: nutugen@kenes.com

Sponsorship & Exhibition Inquiries
Mr. Muzaffer Komek
Industry Liaison & Sales Manager
E-mail: mkomek@kenes.com